Aurinia Pharmaceuticals Inc. (IKAP)
Market Closed
3 Jun, 20:00
XFRA 
€
13. 75
+0.88
+6.8%
€
- Market Cap
- P/E Ratio
- Div Yield
105 Volume
-0.52 Eps
€ 12.88
Previous Close Want to track IKAP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.22 | - |
| | | 0.22 | - |
| | | 0.16 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
IKAP Earnings Reports FAQ
What is the earnings per share (EPS) for IKAP?
The current EPS is -0.52.
What is the company's earnings growth rate?
Aurinia Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Aurinia Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Aurinia Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for IKAP at this time, as Aurinia Pharmaceuticals Inc has no recent EPS data to calculate it.
